Published in Anticancer Res on May 13, 1998
Selenium: biochemical role as a component of glutathione peroxidase. Science (1973) 10.49
Selenium: relation to decreased toxicity of methylmercury added to diets containing tuna. Science (1972) 2.12
In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res (2000) 2.06
Experimental models of traumatic brain injury: do we really need to build a better mousetrap? Neuroscience (2005) 1.71
Reduction of the selenotrisulfide derivative of glutathione to a persulfide analog by glutathione reductase. Biochemistry (1971) 1.64
Selenotrisulfides. Formation by the reaction of thiols with selenious acid. Biochemistry (1968) 1.61
Dietary control of selenium volatilization in the rat. J Nutr (1966) 1.59
N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res (1979) 1.56
Glutathione peroxidase activity of glutathione-s-transferases purified from rat liver. Biochem Biophys Res Commun (1976) 1.41
Reimbursement for acute care nurse practitioner services. Am J Crit Care (2000) 1.40
A comparison of the histopathology of premalignant and malignant mammary gland lesions induced in sexually immature rats with those occurring in the human. Lab Invest (2000) 1.32
Selenium and glutathione peroxidase in developing rat brain. J Neurochem (1976) 1.31
Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res (1994) 1.25
Selenium as a component of glutathione periodase isolated from ovine erythrocytes. Biochemistry (1974) 1.24
Acid-volatile selenium formation catalyzed by glutathione reductase. Biochemistry (1975) 1.23
Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res (1991) 1.21
Self-help activities in cocaine dependent patients entering treatment: results from NIDA collaborative cocaine treatment study. Drug Alcohol Depend (1996) 1.17
Triphenylselenonium and diphenylselenide in cancer chemoprevention: comparative studies of anticarcinogenic efficacy, tissue selenium levels and excretion profile. Anticancer Res (1998) 1.13
Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J Nutr (1999) 1.12
Effect of caloric restriction on pre-malignant and malignant stages of mammary carcinogenesis. Carcinogenesis (1997) 1.08
Relative cadmium-binding capacity of metallothionein and other cytosolic fractions in various tissues of the rat. Environ Physiol Biochem (1975) 1.06
Activity of methylated forms of selenium in cancer prevention. Cancer Res (1990) 1.06
Selenotrisulfides. II. Cross-linking of reduced pancreatic ribonuclease with selenium. Biochemistry (1969) 1.06
Manifestations of chronic selenium deficiency in a child receiving total parenteral nutrition. Am J Clin Nutr (1983) 1.04
Delayed inhibition of Nogo-A does not alter injury-induced axonal sprouting but enhances recovery of cognitive function following experimental traumatic brain injury in rats. Neuroscience (2005) 1.04
Early prediction of initiation of abstinence from cocaine. Use of a craving questionnaire. Am J Addict (1997) 1.03
Dietary vanadyl(IV) sulfate inhibits chemically-induced mammary carcinogenesis. Carcinogenesis (1984) 1.02
Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology (1994) 1.02
Differential induction of growth arrest inducible genes by selenium compounds. Biochem Pharmacol (1997) 1.01
Energy availability and mammary carcinogenesis: effects of calorie restriction and exercise. Carcinogenesis (1997) 1.01
Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland. Cancer Epidemiol Biomarkers Prev (2000) 1.01
Gene expression changes associated with chemically induced rat mammary carcinogenesis. Mol Carcinog (1997) 1.00
Effect of fixation and epitope retrieval on BrdU indices in mammary carcinomas. J Histochem Cytochem (2000) 0.99
N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids. Cancer Res (1981) 0.98
Prevention of oxidative damage to rat erythrocytes by dietary selenium. J Nutr (1972) 0.98
Defective microbicidal activity in glutathione peroxidase-deficient neutrophils of selenium-deficient rats. Nature (1975) 0.97
Effect on an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention. Carcinogenesis (1996) 0.97
Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem Pharmacol (1994) 0.97
Modification of methylmercury toxicity and metabolism by selenium and vitamin E: possible mechanisms. Environ Health Perspect (1978) 0.96
Conjugated linoleic acid. A powerful anticarcinogen from animal fat sources. Cancer (1994) 0.96
Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells. Cancer Lett (1999) 0.94
Enzymic synthesis of dimethyl selenide from sodium selenite in mouse liver extracts. Biochemistry (1966) 0.93
Affinity labelling studies with 109cadmium in cadmium-induced testicular injury in rats. J Reprod Fertil (1974) 0.92
Comparison of selenium and sulfur analogs in cancer prevention. Carcinogenesis (1992) 0.91
Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat. Anticancer Res (2000) 0.90
Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis. Mol Carcinog (1999) 0.90
Selenium-enriched garlic inhibits the early stage but not the late stage of mammary carcinogenesis. Carcinogenesis (1996) 0.89
Interactions between selenium and methylmercury in rat brain. Chem Biol Interact (1977) 0.89
Journey towards recovery following physical trauma. J Adv Nurs (2000) 0.87
The metabolism of selenomethionine, Se-methylselenocysteine, their selenonium derivatives, and trimethylselenonium in the rat. Arch Biochem Biophys (1986) 0.87
Effect of energy restriction on tissue size regulation during chemically induced mammary carcinogenesis. Carcinogenesis (1999) 0.87
Antioxidant status and dietary lipid unsaturation modulate oxidative DNA damage. Free Radic Biol Med (1994) 0.87
Retention of conjugated linoleic acid in the mammary gland is associated with tumor inhibition during the post-initiation phase of carcinogenesis. Carcinogenesis (1997) 0.86
Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine. Cancer Res (1978) 0.86
Induction of mammary gland carcinomas by the subcutaneous injection of 1-methyl-1-nitrosourea. Cancer Res (1983) 0.85
Effects of dietary selenium and tocopherol on glutathione peroxidase and superoxide dismutase activities in rat phagocytes. Life Sci (1976) 0.85
Glutathione peroxidase: inhibition by cyanide and release of selenium. Biochem Biophys Res Commun (1977) 0.85
Methylseleninic acid, a potent growth inhibitor of synchronized mouse mammary epithelial tumor cells in vitro. Biochem Pharmacol (2001) 0.85
The efficacy of conjugated linoleic acid in mammary cancer prevention is independent of the level or type of fat in the diet. Carcinogenesis (1996) 0.85
Plasma xanthophyll carotenoids correlate inversely with indices of oxidative DNA damage and lipid peroxidation. Cancer Epidemiol Biomarkers Prev (2000) 0.84
X-radiation induces 8-hydroxy-2'-deoxyguanosine formation in vivo in rat mammary gland DNA. Carcinogenesis (1998) 0.83
Selenium inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis in the rat. J Natl Cancer Inst (1980) 0.83
ras may mediate mammary cancer promotion by high fat. Nutr Cancer (1995) 0.83
Metabolites of sodium selenite and methylated selenium compounds administered at cancer chemoprevention levels in the rat. Xenobiotica (1993) 0.83
Effect of the aromatase inhibitor vorozole on estrogen and progesterone receptor content of rat mammary carcinomas induced by 1-methyl-1-nitrosourea. Breast Cancer Res Treat (2001) 0.83
Pathogenic characterization of 1-methyl-1-nitrosourea-induced mammary carcinomas in the rat. Carcinogenesis (1998) 0.83
Selenium content of commercial formula diets. Am J Clin Nutr (1978) 0.83
Identification of hydrogen selenide and other volatile selenols by derivatization with 1-fluoro-2,4-dinitrobenzene. Anal Biochem (1984) 0.83
Se-methylselenocysteine activates caspase-3 in mouse mammary epithelial tumor cells in vitro. Biofactors (2001) 0.82
Effect of corticosterone administration on mammary gland development and p27 expression and their relationship to the effects of energy restriction on mammary carcinogenesis. Carcinogenesis (1998) 0.82
Alleviation of silver toxicity by selenite in the rat in relation to tissue glutathione peroxidase. Proc Soc Exp Biol Med (1975) 0.82
Effect of an inorganic and organic form of dietary selenium on the promotional stage of mammary carcinogenesis in the rat. Cancer Res (1984) 0.81
Some properties of a unique cadmium-binding moiety in the soluble fraction of rat testes. Environ Physiol Biochem (1975) 0.81
Vanadium complexes of transferrin and ferritin in the rat. Biochim Biophys Acta (1986) 0.81
A mutual protective effect of mercury and selenium in Japanese quail. Poult Sci (1977) 0.81
Control of rat mammary epithelium proliferation by conjugated linoleic acid. Nutr Cancer (2001) 0.81
Oxidation states of glutathione peroxidase. Methods Enzymol (1984) 0.80
Effect of combined selenium and retinyl acetate treatment on mammary carcinogenesis. Cancer Res (1981) 0.80
Effect of concentration of D,L-2-difluoromethylornithine on murine mammary carcinogenesis. Cancer Res (1985) 0.80
Cyclic food restriction alters substrate utilization and abolishes protection from mammary carcinogenesis female rats. J Nutr (1996) 0.80
Mobilizing Older Adults: Harnessing the Potential of Smart Home Technologies. Contribution of the IMIA Working Group on Smart Homes and Ambient Assisted Living. Yearb Med Inform (2012) 0.80
Biosynthesis of dimethyl selenide from sodium selenite in rat liver and kidney cell-free systems. Biochim Biophys Acta (1977) 0.80
Telomerase activity in the normal and neoplastic rat mammary gland. Cancer Res (1997) 0.79
Effect of excess dietary iron on the promotion stage of 1-methyl-1-nitrosourea-induced mammary carcinogenesis: pathogenetic characteristics and distribution of iron. Carcinogenesis (1994) 0.79
Reaction of cyanide with glutathione peroxidase. Biochem Biophys Res Commun (1980) 0.79
Treatment with chemopreventive agents, difluoromethylornithine and retinyl acetate, results in altered mammary extracellular matrix. Carcinogenesis (1995) 0.79
Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents. Anticancer Res (1999) 0.79
Effect of conjoint administration of tamoxifen and high-dose radiation on the development of mammary carcinoma. Int J Radiat Oncol Biol Phys (1993) 0.79
Microsatellite instability in an animal model of mammary carcinogenesis. Int J Oncol (1998) 0.79
In vitro effects of Se-allylselenocysteine and Se-propylselenocysteine on cell growth, DNA integrity, and apoptosis. Biochem Pharmacol (2000) 0.79
O-methyltransferases of furanocoumarin biosynthesis. Arch Biochem Biophys (1978) 0.78
Histogenesis and dose dependence of N-methyl-N-nitrosourea-induced carcinoma in a localized area of the hamster trachea. J Natl Cancer Inst (1980) 0.78
A quantitative dosing schedule for the induction of transitional cell carcinomas in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl)nitrosamine. J Natl Cancer Inst (1979) 0.78
Combination of blocking agents and suppressing agents in cancer prevention. Carcinogenesis (1991) 0.78
Gluconeogenesis in isolated rat hepatic parenchymal cells. IX. Differential effects of glucagon and epinephrine on phosphofructokinase and pyruvate kinase. Mayo Clin Proc (1976) 0.78